News

FDA Bans Generic Version of Oxycontin
On the day when the patent for the original version of OxyContin was set to…

Generic Zovirax® Launches
On Wednesday, April 3, generic Zovirax® ointment launched. Annual US brand sales of the 30gm…

Generic Luvox® CR Launches
On March 13, Par Pharmaceuticals received final FDA approval and launched the generic equivalent of…

William Lee Promoted to National Sales Manager
Carlisle Medical is proud to announce the promotion of William Lee to National Sales Manager….

John Means Promoted to Regional Sales Manager
Carlisle Medical is proud to announce the promotion of John Means to Regional Sales Manager….

Carlisle Medical Welcomes Account Executive Jade Edwards!
Carlisle Medical is pleased to announce that Jade Edwards has joined our team as an…

Carlisle Medical Welcomes National Account Executive Bill Blankinship!
Carlisle Medical is pleased to announce that William M. Blankinship, CIC, CRM (Bill), has joined…

Congrats to Jennie Rivers on 25 Years with Carlisle & Associates!
It is with great pride that we announce Jennie Rivers’ 25th anniversary at Carlisle &…

Changes to the Controlled Substance Schedules – New York
Changes to the Controlled Substance Schedules in Section 3306 of the New York State Public…

Generic Zometa® Launches
Generic Zometa® Launches – On March 5, 2013, Sagent Pharmaceuticals received final FDA approval and…